Business Wire06.22.17
Exactech Inc., a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee, and hip, announced that the company marked the first clinical use of recently approved shoulder, knee, and hip replacement systems in Japan this quarter. These surgeries coincide with the series of new product introductions the company has reported in the U.S.
Exactech has gained regulatory approval to introduce additional products from each of its three major product segments to the Japanese market. The first Optetrak Logic CR knee system was implanted on April 6 at Taketa Medical Association Hospital in Oita. The Novation Crown Cup acetabular component debuted on April 26 in Ukubo City. The first Exactech total hip replacement surgery in Japan took place on May 16 at the Taketa Medical Association Hospital when a surgeon implanted the Alteon Tapered Wedge Stem along with the Crown Cup. The first Equinoxe Reverse Shoulder system was implanted June 5 at Sano Memorial Hospital.
“Exactech has maintained direct distribution in Japan since 2008 with consistent growth. These new product introductions are important milestones for Exactech in one of our key global markets,” said Exactech vice president of international sales and market development Daniel Berdat. “We are pleased to expand our offerings with these important innovations to better serve surgeons and patients.”
Exactech has gained regulatory approval to introduce additional products from each of its three major product segments to the Japanese market. The first Optetrak Logic CR knee system was implanted on April 6 at Taketa Medical Association Hospital in Oita. The Novation Crown Cup acetabular component debuted on April 26 in Ukubo City. The first Exactech total hip replacement surgery in Japan took place on May 16 at the Taketa Medical Association Hospital when a surgeon implanted the Alteon Tapered Wedge Stem along with the Crown Cup. The first Equinoxe Reverse Shoulder system was implanted June 5 at Sano Memorial Hospital.
“Exactech has maintained direct distribution in Japan since 2008 with consistent growth. These new product introductions are important milestones for Exactech in one of our key global markets,” said Exactech vice president of international sales and market development Daniel Berdat. “We are pleased to expand our offerings with these important innovations to better serve surgeons and patients.”